Search Results - "Pedraz, J L"

Refine Results
  1. 1

    Pharmacokinetics of Benznidazole in Healthy Volunteers and Implications in Future Clinical Trials by Molina, I, Salvador, F, Sánchez-Montalvá, A, Artaza, M A, Moreno, R, Perin, L, Esquisabel, A, Pinto, L, Pedraz, J L

    Published in Antimicrobial agents and chemotherapy (01-04-2017)
    “…Despite its toxicity and low efficacy in the chronic phase, benznidazole is the drug of choice in Chagas disease. Scarce information about pharmacokinetics and…”
    Get full text
    Journal Article
  2. 2

    The state-of-the-art of approved and under-development cholera vaccines by Pastor, M, Pedraz, J.L, Esquisabel, A

    Published in Vaccine (28-08-2013)
    “…Highlight • Cholera has re-emerged as a public health issue, mainly due to recent outbreaks. • Oral cholera vaccines are recommended by WHO since 1999 as a…”
    Get full text
    Journal Article
  3. 3

    Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine by Puras, G, Martínez-Navarrete, G, Mashal, M, Zárate, J, Agirre, M, Ojeda, E, Grijalvo, S, Eritja, R, Diaz-Tahoces, A, Avilés-Trigueros, M, Fernández, E, Pedraz, J. L

    Published in Molecular pharmaceutics (05-10-2015)
    “…The present study aimed to evaluate the incorporation of protamine into niosome/DNA vectors to analyze the potential application of this novel ternary…”
    Get full text
    Journal Article
  4. 4

    Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres by Gutierro, I, Hernández, R.M, Igartua, M, Gascón, A.R, Pedraz, J.L

    Published in Vaccine (22-11-2002)
    “…BSA was entrapped in particles of different sizes (200, 500 and 1000 nm) prepared from poly( d, l-lactic-co-glycolic) acid by a double emulsion method. The…”
    Get full text
    Journal Article
  5. 5

    Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy by del Pozo-Rodríguez, A., Solinís, M.A., Gascón, A.R., Pedraz, J.L.

    “…Most studies in gene therapy are focused on developing more efficient non-viral vectors, ignoring their stability, even though physically and chemically stable…”
    Get full text
    Journal Article
  6. 6

    A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors by del Pozo-Rodríguez, A., Pujals, S., Delgado, D., Solinís, M.A., Gascón, A.R., Giralt, E., Pedraz, J.L.

    Published in Journal of controlled release (05-01-2009)
    “…The aim of this work was to improve the transfection efficacy of solid lipid nanoparticle (SLN)-based non-viral vectors into ARPE-19 cells through the addition…”
    Get full text
    Journal Article
  7. 7

    Solid lipid nanoparticles for retinal gene therapy: Transfection and intracellular trafficking in RPE cells by del Pozo-Rodríguez, A., Delgado, D., Solinís, M.A., Gascón, A.R., Pedraz, J.L.

    Published in International journal of pharmaceutics (06-08-2008)
    “…Retinal pigment epithelial (RPE) cells are usually employed to study DNA systems for diseases related to problems in the retina. Solid lipid nanoparticles…”
    Get full text
    Journal Article
  8. 8

    Solid lipid nanoparticles: Formulation factors affecting cell transfection capacity by del Pozo-Rodríguez, A., Delgado, D., Solinís, M.A., Gascón, A.R., Pedraz, J.L.

    Published in International journal of pharmaceutics (18-07-2007)
    “…Since solid lipid nanoparticles (SLNs) were introduced as non-viral transfection systems, very few reports of their use for gene delivery have been published…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Optimization of 100μm alginate-poly-l-lysine-alginate capsules for intravitreous administration by Santos, E., Orive, G., Calvo, A., Catena, R., Fernández-Robredo, P., Layana, A. García, Hernández, R.M., Pedraz, J.L.

    Published in Journal of controlled release (28-03-2012)
    “…The field of cell microencapsulation is advancing rapidly. Particle size plays a critical role in terms of biocompatibility and limits decisively its…”
    Get full text
    Journal Article
  11. 11

    Low molecular-weight hyaluronan as a cryoprotectant for the storage of microencapsulated cells by Gurruchaga, H., Saenz del Burgo, L., Orive, G., Hernandez, R.M., Ciriza, J., Pedraz, J.L.

    Published in International journal of pharmaceutics (05-09-2018)
    “…[Display omitted] The low-temperature storage of therapeutic cell-based products plays a crucial role in their clinical translation for the treatment of…”
    Get full text
    Journal Article
  12. 12

    Biocompatibility Evaluation of Different Alginates and Alginate-Based Microcapsules by Orive, G, Carcaboso, A. M, Hernández, R. M, Gascón, A. R, Pedraz, J. L

    Published in Biomacromolecules (01-03-2005)
    “…Biocompatibility of biomaterials and biomaterial-based medical devices is a critical issue for the long-term function on multiple therapeutic systems. In the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates by Orive, G, Ponce, S, Hernández, R.M, Gascón, A.R, Igartua, M, Pedraz, J.L

    Published in Biomaterials (01-09-2002)
    “…The biocompatibility of alginate-PLL-alginate (APA) microcapsules has been evaluated with respect to impurity levels. The impurity content of three different…”
    Get full text
    Journal Article
  15. 15

    Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation by Ochoa, L., Igartua, M., Hernández, R.M., Gascón, A.R., Solinis, M.A., Pedraz, J.L.

    “…The novel extended-release formulation of lovastatin developed exhibits zero-order release in vitro and provides extended plasma levels of lovastatin and its…”
    Get full text
    Journal Article
  16. 16

    Cell Microencapsulation and Cryopreservation with Low Molecular Weight Hyaluronan and Dimethyl Sulfoxide by Gurruchaga, H, Del Burgo, L Saenz, Orive, G, M Hernandez, R, Ciriza, J, L Pedraz, J

    Published in Bio-protocol (20-02-2019)
    “…Cryopreservation is commonly used for the storage of cells, tissues, organs or 3D cell-based products using ultra-low temperatures, which involves the…”
    Get full text
    Journal Article
  17. 17

    Engineering a Clinically Translatable Bioartificial Pancreas to Treat Type I Diabetes by Orive, Gorka, Emerich, Dwaine, Khademhosseini, Ali, Matsumoto, Shinichi, Hernández, R.M., Pedraz, J.L., Desai, Tejal, Calafiore, Riccardo, de Vos, Paul

    Published in Trends in biotechnology (Regular ed.) (01-04-2018)
    “…Encapsulating, or immunoisolating, insulin-secreting cells within implantable, semipermeable membranes is an emerging treatment for type 1 diabetes. This…”
    Get full text
    Journal Article
  18. 18

    Survival of different cell lines in alginate-agarose microcapsules by Orive, G, Hernández, R.M, Gascón, A.R, Igartua, M, Pedraz, J.L

    “…Cell microencapsulation has emerged as a promising therapeutic strategy to treat a wide range of diseases. The optimisation of this technology depends on…”
    Get full text
    Journal Article
  19. 19

    Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy by Moreno-Sastre, M, Pastor, M, Salomon, C J, Esquisabel, A, Pedraz, J L

    Published in Journal of antimicrobial chemotherapy (01-11-2015)
    “…As the WHO stated, lower respiratory infections are the third leading cause of death. In addition, it is remarkable that antimicrobial resistance represents a…”
    Get full text
    Journal Article
  20. 20